Published in Medicine and Law Weekly, October 15th, 2004
This patent is an important addition to the company's revolutionary technology platform known as "T-Cell Capture" (TCC).
Artificial antigen presenting cells, the structure of which closely resembles their physiologic equivalents, can induce T-cells to react in a physiologic fashion. This is achieved in an entirely artificial system, in which the composition and relative concentrations of the reagents are fully controllable.
The patent claims artificial antigen presenting cell compositions that are broadly applicable...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medicine and Law Weekly